Back to top

EXHIBIT 10.30 SHAREHOLDERS AGREEMENT

Shareholder Agreement

EXHIBIT 10.30   SHAREHOLDERS AGREEMENT | Document Parties: CYTORI THERAPEUTICS, INC. You are currently viewing:
This Shareholder Agreement involves

CYTORI THERAPEUTICS, INC.

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: EXHIBIT 10.30 SHAREHOLDERS AGREEMENT
Governing Law: Delaware     Date: 3/30/2006

EXHIBIT 10.30   SHAREHOLDERS AGREEMENT, Parties: cytori therapeutics  inc.
50 of the Top 250 law firms use our Products every day
+ADw-html xmlns:v+AD0AIg-urn:schemas-microsoft-com:vml+ACI- xmlns:o+AD0AIg-urn:schemas-microsoft-com:office:office+ACI- xmlns:w+AD0AIg-urn:schemas-microsoft-com:office:word+ACI- xmlns+AD0AIg-http://www.w3.org/TR/REC-html40+ACIAPg- +ADw-head+AD4- +ADw-meta http-equiv+AD0-Content-Type content+AD0AIg-text/html+ADs- charset+AD0-utf-7+ACIAPg- +ADw-meta name+AD0-ProgId content+AD0-Word.Document+AD4- +ADw-meta name+AD0-Generator content+AD0AIg-Microsoft Word 11+ACIAPg- +ADw-meta name+AD0-Originator content+AD0AIg-Microsoft Word 11+ACIAPg- +ADw-link rel+AD0-File-List href+AD0AIg-a06-2389+AF8-1ex10d30+AF8-150+AF8-files/filelist.xml+ACIAPg- +ADw-link rel+AD0-Edit-Time-Data href+AD0AIg-a06-2389+AF8-1ex10d30+AF8-150+AF8-files/editdata.mso+ACIAPg- +ADwAIQ---+AFs-if +ACE-mso+AF0APg- +ADw-style+AD4- v+AFw-:+ACo- +AHs-behavior:url(+ACM-default+ACM-VML)+ADsAfQ- o+AFw-:+ACo- +AHs-behavior:url(+ACM-default+ACM-VML)+ADsAfQ- w+AFw-:+ACo- +AHs-behavior:url(+ACM-default+ACM-VML)+ADsAfQ- .shape +AHs-behavior:url(+ACM-default+ACM-VML)+ADsAfQ- +ADw-/style+AD4- +ADwAIQBb-endif+AF0---+AD4- +ADw-title+AD4-EXHIBIT 10+ADw-/title+AD4- +ADwAIQ---+AFs-if gte mso 9+AF0APgA8-xml+AD4- +ADw-o:DocumentProperties+AD4- +ADw-o:Author+AD4-PTISYS+ADw-/o:Author+AD4- +ADw-o:LastAuthor+AD4-PTI+ADw-/o:LastAuthor+AD4- +ADw-o:Revision+AD4-2+ADw-/o:Revision+AD4- +ADw-o:TotalTime+AD4-0+ADw-/o:TotalTime+AD4- +ADw-o:Created+AD4-2006-08-17T08:28:00Z+ADw-/o:Created+AD4- +ADw-o:LastSaved+AD4-2006-08-17T08:28:00Z+ADw-/o:LastSaved+AD4- +ADw-o:Pages+AD4-1+ADw-/o:Pages+AD4- +ADw-o:Words+AD4-10628+ADw-/o:Words+AD4- +ADw-o:Characters+AD4-60582+ADw-/o:Characters+AD4- +ADw-o:Company+AD4-Practice Technologies, Inc.+ADw-/o:Company+AD4- +ADw-o:Lines+AD4-504+ADw-/o:Lines+AD4- +ADw-o:Paragraphs+AD4-142+ADw-/o:Paragraphs+AD4- +ADw-o:CharactersWithSpaces+AD4-71068+ADw-/o:CharactersWithSpaces+AD4- +ADw-o:Version+AD4-11.6568+ADw-/o:Version+AD4- +ADw-/o:DocumentProperties+AD4- +ADw-/xml+AD4APAAhAFs-endif+AF0---+AD4APAAh---+AFs-if gte mso 9+AF0APgA8-xml+AD4- +ADw-w:WordDocument+AD4- +ADw-w:ValidateAgainstSchemas/+AD4- +ADw-w:SaveIfXMLInvalid+AD4-false+ADw-/w:SaveIfXMLInvalid+AD4- +ADw-w:IgnoreMixedContent+AD4-false+ADw-/w:IgnoreMixedContent+AD4- +ADw-w:AlwaysShowPlaceholderText+AD4-false+ADw-/w:AlwaysShowPlaceholderText+AD4- +ADw-w:BrowserLevel+AD4-MicrosoftInternetExplorer4+ADw-/w:BrowserLevel+AD4- +ADw-/w:WordDocument+AD4- +ADw-/xml+AD4APAAhAFs-endif+AF0---+AD4APAAh---+AFs-if gte mso 9+AF0APgA8-xml+AD4- +ADw-w:LatentStyles DefLockedState+AD0AIg-false+ACI- LatentStyleCount+AD0AIg-156+ACIAPg- +ADw-/w:LatentStyles+AD4- +ADw-/xml+AD4APAAhAFs-endif+AF0---+AD4- +ADw-style+AD4- +ADwAIQ--- /+ACo- Style Definitions +ACo-/ p.MsoNormal, li.MsoNormal, div.MsoNormal +AHs-mso-style-parent:+ACIAIgA7- margin:0in+ADs- margin-bottom:.0001pt+ADs- mso-pagination:widow-orphan+ADs- font-size:12.0pt+ADs- font-family:+ACI-Times New Roman+ACIAOw- mso-fareast-font-family:+ACI-Times New Roman+ACIAOwB9- p +AHs-mso-margin-top-alt:auto+ADs- margin-right:0in+ADs- mso-margin-bottom-alt:auto+ADs- margin-left:0in+ADs- mso-pagination:widow-orphan+ADs- font-size:12.0pt+ADs- font-family:+ACI-Times New Roman+ACIAOw- mso-fareast-font-family:+ACI-Times New Roman+ACIAOwB9- +AEA-page Section1 +AHs-size:8.5in 11.0in+ADs- margin:1.0in 1.25in 1.0in 1.25in+ADs- mso-header-margin:.5in+ADs- mso-footer-margin:.5in+ADs- mso-paper-source:0+ADsAfQ- div.Section1 +AHs-page:Section1+ADsAfQ- --+AD4- +ADw-/style+AD4- +ADwAIQ---+AFs-if gte mso 10+AF0APg- +ADw-style+AD4- /+ACo- Style Definitions +ACo-/ table.MsoNormalTable +AHs-mso-style-name:+ACI-Table Normal+ACIAOw- mso-tstyle-rowband-size:0+ADs- mso-tstyle-colband-size:0+ADs- mso-style-noshow:yes+ADs- mso-style-parent:+ACIAIgA7- mso-padding-alt:0in 5.4pt 0in 5.4pt+ADs- mso-para-margin:0in+ADs- mso-para-margin-bottom:.0001pt+ADs- mso-pagination:widow-orphan+ADs- font-size:10.0pt+ADs- font-family:+ACI-Times New Roman+ACIAOw- mso-ansi-language:+ACM-0400+ADs- mso-fareast-language:+ACM-0400+ADs- mso-bidi-language:+ACM-0400+ADsAfQ- +ADw-/style+AD4- +ADwAIQBb-endif+AF0---+AD4- +ADw-/head+AD4- +ADw-body lang+AD0-EN-US style+AD0-'tab-interval:.5in'+AD4- +ADw-div class+AD0-Section1+AD4- +ADw-div+AD4- +ADw-p align+AD0-right style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:right'+AD4APA-b+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-EXHIBIT 10.30+ADw-/span+AD4APA-/b+AD4APA-/p+AD4- +ADw-p align+AD0-right style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:right'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p align+AD0-center style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:center'+AD4APA-u+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-SHAREHOLDERS AGREEMENT+ADw-/span+AD4APA-/u+AD4APA-/p+AD4- +ADw-p align+AD0-center style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:center'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-THIS SHAREHOLDERS AGREEMENT (this +IBwAPA-b+AD4APA-u+AD4-Agreement+ADw-/u+AD4APA-/b+AD4gHQ-), is entered into as of this +ACY-nbsp+ADs-4th+ACY-nbsp+ADs- day of November, 2005, (the +IBwAPA-b+AD4APA-u+AD4-Effective Date+ADw-/u+AD4APA-/b+AD4gHQ-), by and among +ADw-b+AD4-CYTORI, THERAPEUTICS, INC. +ADw-/b+AD4-(+ADw-i+AD4-formerly +ADw-b+AD4-MACROPORE BIOSURGERY, INC+ADw-/b+AD4-.+ADw-/i+AD4-), a Delaware corporation with its principal place of business located at +ACM-3020 Callan Road, San Diego, CA 92121, U.S.A. (+IBwAPA-b+AD4APA-u+AD4-Cytori+ADw-/u+AD4APA-/b+AD4gHQ-), and +ADw-b+AD4-OLYMPUS CORPORATION+ADw-/b+AD4-, a Japanese corporation with its principal office at 2-43-2 Hatagaya Shibuya-ku, Tokyo, Japan+AF0- (+IBwAPA-b+AD4APA-u+AD4-Olympus+ADw-/u+AD4APA-/b+AD4gHQ-).+ADw-o:p+AD4APA-/o:p+AD4APA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(Cytori and Olympus may each be individually referred to herein as a +IBwAPA-b+AD4APA-u+AD4-Shareholder+ADw-/u+AD4APA-/b+AD4gHQ- and collectively as the +IBwAPA-b+AD4APA-u+AD4-Shareholders+ADw-/u+AD4APA-/b+AD4gHQ-.)+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p align+AD0-center style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:center'+AD4APA-u+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-RECITALS+ADw-/span+AD4APA-/u+AD4APA-/p+AD4- +ADw-p align+AD0-center style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:center'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-A. Cytori has acquired and possesses, through the expenditure of considerable time, effort and money, certain intellectual property rights (including patents, patent applications and technical information) to regenerative cell technology, including scientific equipment used to carry out regenerative cell therapies and treatments.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-B. Olympus is a leading developer and manufacturer of medical and scientific equipment and has acquired and possesses, through the expenditure of considerable time, effort and money, certain intellectual property rights (including patents, patent applications and technical information) related to medical and scientific equipment.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-C. Olympus and Cytori entered into a confidentiality agreement dated November 30, 2004 (the +IBwAPA-b+AD4APA-u+AD4-Confidentiality Agreement+ADw-/u+AD4APA-/b+AD4gHQ-).+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-D. Olympus and Cytori entered into a stock purchase agreement dated April 28, 2005 pursuant to which Olympus acquired 1,100,000 common shares of Cytori.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-E. Olympus and Cytori entered into a Joint Venture Agreement dated as of November 4, 2005 (the +IBwAPA-b+AD4APA-u+AD4-JVA+ADw-/u+AD4APA-/b+AD4gHQ-) that, among other things, sets forth the terms and conditions on which Olympus will purchase shares of NewCo stock so that NewCo will be equally owned by Cytori and Olympus.+ADw-o:p+AD4APA-/o:p+AD4APA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-F. In accordance with Sections 7 and 8 of the JVA, the Shareholders and NewCo desire to enter into this Agreement to set forth, among other things, certain terms regarding the operation and management of NewCo.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-NOW, THEREFORE, in consideration of the premises and the mutual covenants set forth herein, the parties hereto hereby agree as follows:+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p align+AD0-center style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:center'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-SECTION 1+ADw-u+AD4APA-br+AD4- DEFINITIONS+ADw-/u+AD4APA-/span+AD4APA-/p+AD4- +ADw-p align+AD0-center style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:center'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-1.1+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Defined Terms+ADw-/u+AD4-. As used in this Agreement, all capitalized terms shall have the meanings ascribed to them as set forth in +ADw-u+AD4-Attachment 1+ADw-/u+AD4-.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-1.2+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-References+ADw-/u+AD4-. In this Agreement, a reference to:+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(a)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- A Section, Sub-section, Recital, Attachment, Schedule or Exhibit is, unless the context otherwise requires, a reference to a section or sub-section of, or a recital, schedule or exhibit to, this Agreement+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p align+AD0-center style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:center'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-div+AD4- +ADw-div class+AD0-MsoNormal+AD4- +ADw-hr size+AD0-2 width+AD0AIg-100+ACUAIg- noshade color+AD0-gray align+AD0-left+AD4- +ADw-/div+AD4- +ADw-/div+AD4- +ADw-/div+AD4- +ADw-span style+AD0-'font-size:12.0pt+ADs-font-family:+ACI-Times New Roman+ACIAOw-mso-fareast-font-family: +ACI-Times New Roman+ACIAOw-mso-ansi-language:EN-US+ADs-mso-fareast-language:EN-US+ADs- mso-bidi-language:AR-SA'+AD4APA-br clear+AD0-all style+AD0-'page-break-before:always'+AD4- +ADw-/span+AD4- +ADw-p align+AD0-center style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:center'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(b)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- This Agreement (or any specific provision hereof) or any other document shall be construed as references to this Agreement, that provision or that other document as amended, varied or modified from time to time+ADs- and+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-1.3+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Headings+ADw-/u+AD4-. Headings in this Agreement are for ease of reference only and shall not affect the interpretation or construction of this Agreement.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-1.4+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Attachments, Schedules and Exhibits+ADw-/u+AD4-. The Attachments, Schedules and Exhibits attached hereto form a part of this Agreement.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-1.5+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Construction+ADw-/u+AD4-. In construing this Agreement, words denoting the singular include the plural and vice versa and words denoting one gender include all genders.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p align+AD0-center style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:center'+AD4-+ADw-span style+AD0-'font-size:10.0pt'+AD4-SECTION 2+ADw-br+AD4- +ADw-u+AD4-SHAREHOLDER MEETINGS+ADw-/u+AD4APA-/span+AD4APA-/p+AD4- +ADw-p align+AD0-center style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:center'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:24.0pt'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-2.1+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-General Principles+ADw-/u+AD4-. The Shareholders agree to (i) take all actions reasonably necessary, including, without limitation, voting their Shares, to cause NewCo to be managed in accordance with the terms of this Agreement, and (ii) use their reasonable commercial efforts, including, without limitation, voting their Shares, to cause NewCo to timely satisfy, perform and fulfill all of its obligations set forth in this Agreement. The Shareholders acknowledge that the provisions of this Section 2 shall in no way affect or diminish their obligations arising pursuant to any and all other sections of this Agreement. NewCo shall, at all times and in good faith, cooperate and assist in performing all the provisions of this Agreement, and shall take all such actions as may be necessary or appropriate in order to effectuate the provisions and intentions of this Agreement.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:24.0pt'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:24.0pt'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-2.2+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Shareholders+IBk- Meetings+ADw-/u+AD4-.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:24.0pt'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(c)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Meetings+ADw-/u+AD4-. Meetings of the Shareholders shall be held regularly (and in any event not less than once every year) and at any time upon the written request of any Shareholder given to the other Shareholder. NewCo shall give not less than forty five (45) days+IBk- written notice to each Shareholder of the date, time, location, agenda and means of communication of each of meeting of the Shareholders. Unless otherwise agreed by the Shareholders, all such meetings shall be conducted in English and shall take place at 3020 Callan Road, San Diego, CA 92121, U.S.A., and may be held by means of teleconference or video conference.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(f)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Quorum+ADw-/u+AD4-. In order for resolutions of a Shareholders+IBk- meeting to be valid, there must be represented, in person or by proxy, at any such meeting a quorum consisting of seventy-five percent (75+ACU-) of the total issued and outstanding Shares, unless or except to the extent the representation of a greater percentage of the issued and outstanding Shares is required by Laws.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4-+ADw-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(g)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Shareholders+IBk- Resolutions+ADw-/u+AD4-. Other than those matters requiring approval by both Shareholders set forth in Section 2.2(d) below, all actions and resolutions of the Shareholders at a Shareholders+IBk- meeting shall be made by the requisite vote provided under the laws of the State of Delaware or as otherwise provided in the Certificate of Incorporation. Any such votes by a Shareholder shall be lawfully cast at a duly convened meeting by the holders of the Shares present in person, or by telephone or audio/video conference, or by proxy. Shareholders shall have one vote for each Share that it owns. A resolution in writing signed by duly authorized representatives of each Shareholder shall be treated in all respects as if such resolution had been made at a duly convened meeting of the Shareholders. Resolutions of the Shareholders may be passed without a meeting+ADw-/span+AD4APA-/p+AD4- +ADw-p align+AD0-center style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:center'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-div+AD4- +ADw-div class+AD0-MsoNormal+AD4- +ADw-hr size+AD0-2 width+AD0AIg-100+ACUAIg- noshade color+AD0-gray align+AD0-left+AD4- +ADw-/div+AD4- +ADw-/div+AD4- +ADw-span style+AD0-'font-size:12.0pt+ADs-font-family:+ACI-Times New Roman+ACIAOw-mso-fareast-font-family: +ACI-Times New Roman+ACIAOw-mso-ansi-language:EN-US+ADs-mso-fareast-language:EN-US+ADs- mso-bidi-language:AR-SA'+AD4APA-br clear+AD0-all style+AD0-'page-break-before:always'+AD4- +ADw-/span+AD4- +ADw-p align+AD0-center style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:center'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-autospace:none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-through written consents of each Shareholder that are duly executed by the duly authorized representative of each respective Shareholder.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(h)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Matters Requiring Approval of Both Shareholders+ADw-/u+AD4-. The following matters require the approval of both Shareholders. Provided however, that the approval by Olympus shall only be deemed to have been given upon delivery of Olympus in writing that is duly signed by the then current president. To the extent approval of both Shareholders is not obtained for any such matter, each Shareholder shall, and NewCo shall, use its best efforts to prevent such matter from being effectuated by or with regard to NewCo.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(i)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- any amendment to the Certificate of Incorporation or any amendment, adoption or repeal of By-Laws+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(ii)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- any reorganization, merger (whether or not NewCo is the surviving company), liquidation, migration, dissolution, consolidation or sale or similar disposition of all or substantially all of the assets of NewCo+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(iii)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- any initial public offering of Shares+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(iv)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- except as specifically provided in Section 4.4, any private placement or issuance, sale, transfer, pledge, encumbrance or other disposal of any capital stock, voting securities, or any other equity interest in NewCo, or grant, permit or otherwise authorize any option, agreement, arrangement, commitment, understanding or other right pursuant to which any third party has the right or ability to acquire, split, reclassify or change the rights and privileges of, or redeem, repurchase or otherwise acquire (whether pursuant to any employee stock option plan or otherwise) any equity interest in NewCo+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(v)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- any declaration or payment of a dividend or distribution in the form of assets other than cash, or of any cash dividend which is extraordinary in size or timing+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(vi)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- subject to Section 2.3(d), removal of directors of NewCo, other than by the Shareholder which appointed the director to be removed+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(vii)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- election or removal of NewCo+IBk-s independent auditors+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(viii)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- any borrowing of money or issuance of any debt instrument or guaranty by NewCo+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(ix)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- any change of NewCo+IBk-s fiscal year+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(x)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- conducting any business other than the Business+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(xi)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- any contract or transaction with a Shareholder or an Affiliate of a Shareholder+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(xii)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- any license-out, sublicense-out or assignment of any Intellectual Property Rights, or any disclosure of proprietary information is such a way as to prevent a future claim of trade secret status+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(xiii)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- any capital expenditure (or series of related capital expenditures) above +ACQ-250,000+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(xiv)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- any change in the authorized number of directors of NewCo+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(xv)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- any formation of any Affiliate entity+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p align+AD0-center style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:center'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-div+AD4- +ADw-div class+AD0-MsoNormal+AD4- +ADw-hr size+AD0-2 width+AD0AIg-100+ACUAIg- noshade color+AD0-gray align+AD0-left+AD4- +ADw-/div+AD4- +ADw-/div+AD4- +ADw-span style+AD0-'font-size:12.0pt+ADs-font-family:+ACI-Times New Roman+ACIAOw-mso-fareast-font-family: +ACI-Times New Roman+ACIAOw-mso-ansi-language:EN-US+ADs-mso-fareast-language:EN-US+ADs- mso-bidi-language:AR-SA'+AD4APA-br clear+AD0-all style+AD0-'page-break-before:always'+AD4- +ADw-/span+AD4- +ADw-p align+AD0-center style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:center'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(xvi)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- any acquisition of any equity interest in or transfer of any assets or rights to any entity which is, after the transaction, an Affiliate of Newco+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(xvii)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- any security interest in any NewCo asset+ADs- or+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(xviii)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- any Insolvency filing.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-2.3+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- Board of Directors.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(a)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Composition Board of Directors+ADw-/u+AD4-. NewCo shall be managed by a board of directors of NewCo (the +IBwAPA-b+AD4APA-u+AD4-Board of Directors+ADw-/u+AD4APA-/b+AD4gHQ-), which shall consist of five (5) directors (each, a +IBwAPA-b+AD4APA-u+AD4-Director+ADw-/u+AD4APA-/b+AD4gHQ- and collectively the +IBwAPA-b+AD4APA-u+AD4-Directors+ADw-/u+AD4APA-/b+AD4gHQ-). Olympus shall have the right to appoint three (3) Directors (+IBwAPA-b+AD4APA-u+AD4-Olympus Director(s)+ADw-/u+AD4APA-/b+AD4gHQ-) and Cytori shall have the right to appoint two (2) Directors (+IBwAPA-b+AD4APA-u+AD4-Cytori Director(s)+ADw-/u+AD4APA-/b+AD4gHQ-). The right of a Shareholder to appoint Directors under this Section 2.1 shall be subject to such Shareholder retaining at least +AFs-thirty percent (30+ACU-)+AF0- of the then issued and outstanding Shares (including its Affiliates+IBk- holdings) (the +IBwAPA-b+AD4APA-u+AD4-Threshold Percentage+ADw-/u+AD4APA-/b+AD4gHQ-). If a Shareholder+IBk-s holdings of Shares (including its Affiliates+IBk- holdings) falls below the Threshold Percentage, then such Shareholder shall only have the right to appoint one (1) Director under this Section 2.1, and the other Shareholder shall have right to appoint all other Directors. The initial Cytori Directors and the initial Olympus Directors shall be as provided for in +ADw-u+AD4-Schedule 2.3(a)+ADw-/u+AD4-. The Shareholders shall, promptly following the Effective Date, but in no event later than thirty (30) days following the Effective Date, vote their respective Shares and take all other actions necessary to elect the initial Olympus Directors and the initial Cytori Directors so that following such election of the initial Olympus Directors and the initial Cytori Directors, the Directors will be composed of the directors listed in +ADw-u+AD4-Schedule 2.3(a)+ADw-/u+AD4-.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(i)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Right to Removal and Replacement+ADw-/u+AD4-. Each Shareholder shall have the right, exercisable in its sole discretion and with or without cause, to remove and replace at any time, any Director appointed by it pursuant to Section 2.3(a). For the avoidance of doubt, the Shareholders shall vote their respective Shares to effectuate any such removal and/or replacement.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(j)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Fitness of Appointed Directors+ADw-/u+AD4-. Neither NewCo, the Shareholders, nor any officer, director, shareholder, partner, employee or agent of such party, makes any representation or warranty as to the fitness or competence of the appointee of any Shareholder hereunder to serve on the Board of Directors by virtue of such party+IBk-s execution of this Agreement or by the act of such party in voting for such appointee pursuant hereto.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(k)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Removal Pursuant to Laws+ADw-/u+AD4-. Any Director may be removed for cause in accordance with applicable Laws.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4-+ADw-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(l)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Chairman+ADw-/u+AD4-. Olympus shall appoint the chairman of the Board of Directors (+IBwAPA-b+AD4APA-u+AD4-Chairman+ADw-/u+AD4APA-/b+AD4gHQ-).+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(m)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Quorum+ADw-/u+AD4-. No business shall be transacted at any meeting of the Board of Directors unless there shall be present throughout such meeting a quorum of Directors. Attendance by four (4) Directors at a meeting of the Board of Directors shall constitute a quorum for the transaction of business thereat. If a quorum does not exist for any duly noticed meeting of the Board of Directors, the Directors in attendance at such meeting shall re-schedule the meeting for a date no earlier than three (3) weeks after such meeting and notify each Directors of such rescheduled meeting. For such re-scheduled meeting of the Board of Directors three (3) members of the Board of Directors in attendance shall constitute a quorum for the transaction of business thereat.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(n)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Board of Directors+IBk- Meetings+ADw-/u+AD4-. Board of Directors+IBk- meetings shall be conducted in English and held in accordance with the laws of State of Delaware and convened no less than once each calendar+ADw-/span+AD4APA-/p+AD4- +ADw-p align+AD0-center style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:center'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-div+AD4- +ADw-div class+AD0-MsoNormal+AD4- +ADw-hr size+AD0-2 width+AD0AIg-100+ACUAIg- noshade color+AD0-gray align+AD0-left+AD4- +ADw-/div+AD4- +ADw-/div+AD4- +ADw-span style+AD0-'font-size:12.0pt+ADs-font-family:+ACI-Times New Roman+ACIAOw-mso-fareast-font-family: +ACI-Times New Roman+ACIAOw-mso-ansi-language:EN-US+ADs-mso-fareast-language:EN-US+ADs- mso-bidi-language:AR-SA'+AD4APA-br clear+AD0-all style+AD0-'page-break-before:always'+AD4- +ADw-/span+AD4- +ADw-p align+AD0-center style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:center'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-autospace:none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-quarter unless otherwise agreed by the Shareholders. Not less than fourteen (14) days notice (or such other period of notice as may be agreed from time to time by the Shareholders) of each meeting of the Board of Directors specifying the date, time and place of the meeting and business to be transacted thereat shall be given to all Directors. Directors may participate and vote in person, by telephone or by audio/video conference. The dates and places of Board of Directors meetings shall be agreed upon by the Directors (or, in the case of a re-scheduled meeting, by the Directors in attendance at a Board of Directors meeting for which a quorum did not exist) or, in the absence of such agreement, by the Chairman in accordance with By-Laws.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(o)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Board of Directors+IBk- Resolutions+ADw-/u+AD4-. All actions taken at a meeting of the Board of Directors shall be by the requisite vote provided under the laws of the State of Delaware. Resolutions of the Board of Directors may be passed without a meeting by unanimous written resolution executed by all Directors. All matters that do not require unanimous approval of the Shareholders as provided under Section 2.2(d) or Shareholders+IBk- approval under the laws of the state of Delaware may be determined by Board of Directors+IBk- resolution.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(p)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Remuneration of Directors+ADw-/u+AD4-. The remuneration (if any) of the Directors shall be determined by, and subject to the approval of, both Shareholders.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(q)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Attendance by Invitees+ADw-/u+AD4-. If the Board so authorizes or requests, auditors, consultants, advisers and employees shall be permitted to attend and speak at meetings of the Board, but not to vote.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-2.4+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Officers+ADw-/u+AD4-.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(a)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Appointment of Officers+ADw-/u+AD4-. Unless otherwise agreed by the Shareholders, each Shareholder shall have the right to nominate officers in accordance with +ADw-u+AD4-Schedule 2.4(a)+ADw-/u+AD4-. Each Shareholder shall procure that each of its appointed Directors shall take the necessary and appropriate actions, including, without limitation, voting at Board of Directors meetings, to effectuate the appointment of the persons so nominated.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(r)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Removal of Officers+ADw-/u+AD4-. Each Shareholder shall have the right, exercisable in its sole discretion and with or without cause, to remove and replace at any time, any officer nominated by it pursuant to Section 2.4(a). Each Shareholder shall procure that each of its appointed Directors shall take the necessary and appropriate actions, including, without limitation, voting at Board of Directors meetings, to effectuate any such removal or replacement of an officer pursuant to this Section 2.4(b).+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin-top:0in+ADs-margin-right:0in+ADs-margin-bottom:0in+ADs-margin-left:.5in+ADs- margin-bottom:.0001pt'+AD4APA-span style+AD0-'font-size:10.0pt+ADs-color:black'+AD4-2.5+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Company Name+ADw-/u+AD4-.+ADw-/span+AD4APA-span style+AD0-'font-size:10.0pt'+AD4APA-o:p+AD4APA-/o:p+AD4APA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin-top:0in+ADs-margin-right:0in+ADs-margin-bottom:0in+ADs-margin-left:.5in+ADs- margin-bottom:.0001pt'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in'+AD4APA-span style+AD0-'font-size:10.0pt+ADs-color:black'+AD4-(a)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- Deletion of +IBw-Olympus+IB0-. If Olympus either: (i) in its sole discretion informs the other Shareholder(s) of its desire to cease use by NewCo of any Olympus+ADw-/span+AD4APA-b+AD4APA-span style+AD0-'font-size:10.0pt'+AD4- +ADw-/span+AD4APA-/b+AD4APA-span style+AD0-'font-size:10.0pt+ADs-color:black'+AD4-trademarks (whether as a trademark or in NewCo+IBk-s company name), or (ii) the shareholding of Olympus (including its Affiliates+IBk- holdings) becomes less than thirty percent (30+ACU-) of the outstanding shares of NewCo, then the Shareholders shall take and shall cause NewCo to take, all actions necessary to:+ADw-/span+AD4APA-span style+AD0-'font-size:10.0pt'+AD4APA-o:p+AD4APA-/o:p+AD4APA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin-top:0in+ADs-margin-right:0in+ADs-margin-bottom:0in+ADs-margin-left:1.0in+ADs- margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt+ADs- color:black'+AD4-(i)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- change NewCo+IBk-s corporate name so as to delete +IBw-Olympus+IB0- therefrom+ADs- and+ADw-/span+AD4APA-span style+AD0-'font-size:10.0pt'+AD4APA-o:p+AD4APA-/o:p+AD4APA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin-top:0in+ADs-margin-right:0in+ADs-margin-bottom:0in+ADs-margin-left:1.0in+ADs- margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin-top:0in+ADs-margin-right:0in+ADs-margin-bottom:0in+ADs-margin-left:1.0in+ADs- margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt+ADs- color:black'+AD4-(ii)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- cease use of and make null and void any trademark registration owned by NewCo of trademarks including any trademarks of Olympus,+ADw-/span+AD4APA-span style+AD0-'font-size:10.0pt'+AD4APA-o:p+AD4APA-/o:p+AD4APA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt'+AD4APA-span style+AD0-'font-size:10.0pt+ADs- color:black'+AD4-within a reasonable period of time, which in no event shall be longer than three (3) months from (Y) the date on which Olympus notifies the other Shareholders of its desire for NewCo to cease use of any Olympus trademarks, (Z) the date on which Olympus (including its Affiliates+IBk- holdings) no longer holds thirty percent (30+ACU-) shareholding in NewCo.+ADw-/span+AD4APA-b+AD4APA-o:p+AD4APA-/o:p+AD4APA-/b+AD4APA-/p+AD4- +ADw-p align+AD0-center style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:center'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-div+AD4- +ADw-div class+AD0-MsoNormal+AD4- +ADw-hr size+AD0-2 width+AD0AIg-100+ACUAIg- noshade color+AD0-gray align+AD0-left+AD4- +ADw-/div+AD4- +ADw-/div+AD4- +ADw-span style+AD0-'font-size:12.0pt+ADs-font-family:+ACI-Times New Roman+ACIAOw-mso-fareast-font-family: +ACI-Times New Roman+ACIAOw-mso-ansi-language:EN-US+ADs-mso-fareast-language:EN-US+ADs- mso-bidi-language:AR-SA'+AD4APA-br clear+AD0-all style+AD0-'page-break-before:always'+AD4- +ADw-/span+AD4- +ADw-p align+AD0-center style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:center'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in'+AD4APA-span style+AD0-'font-size:10.0pt+ADs-color:black'+AD4-(b)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- Deletion of +IBw-Cytori+IB0-. If Cytori either: (i) in its sole discretion informs the other Shareholder(s) of its desire to cease use by NewCo of any Cytori trademarks (whether as a trademark or in NewCo+IBk-s company name), or (ii) the shareholding of Cytori (including its Affiliates+IBk- holdings) becomes less than thirty percent (30+ACU-) of the outstanding shares of NewCo, then the Shareholders shall take and shall cause NewCo to take, all actions necessary to:+ADw-/span+AD4APA-span style+AD0-'font-size:10.0pt'+AD4APA-o:p+AD4APA-/o:p+AD4APA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin-top:0in+ADs-margin-right:0in+ADs-margin-bottom:0in+ADs-margin-left:1.0in+ADs- margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt+ADs- color:black'+AD4-(i)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- change NewCo+IBk-s corporate name so as to delete +IBw-Cytori+IB0- therefrom+ADs- and+ADw-/span+AD4APA-span style+AD0-'font-size:10.0pt'+AD4APA-o:p+AD4APA-/o:p+AD4APA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin-top:0in+ADs-margin-right:0in+ADs-margin-bottom:0in+ADs-margin-left:1.0in+ADs- margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin-top:0in+ADs-margin-right:0in+ADs-margin-bottom:0in+ADs-margin-left:1.0in+ADs- margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt+ADs- color:black'+AD4-(ii)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- cease use of and make null and void any trademark registration owned by NewCo of trademarks including any trademarks of Cytori (other than any trademark registrations concerning the Licensed Products that do not include +IBw-Cytori+IB0-),+ADw-/span+AD4APA-span style+AD0-'font-size:10.0pt'+AD4APA-o:p+AD4APA-/o:p+AD4APA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt'+AD4APA-span style+AD0-'font-size:10.0pt+ADs- color:black'+AD4-within a reasonable period of time, which in no event shall be longer than three (3) months from (Y) the date on which Cytori notifies the other Shareholders of its desire for NewCo to cease use of any Cytori trademarks, (Z) the date on which Cytori (including its Affiliates+IBk- holdings) no longer holds thirty percent (30+ACU-) shareholding in NewCo.+ADw-/span+AD4APA-b+AD4APA-o:p+AD4APA-/o:p+AD4APA-/b+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-For the avoidance of doubt, NewCo is not granted any right or authority to use trademarks including any trademarks of Olympus and/or Cytori unless otherwise expressly authorized by Olympus and/or Cytori in writing.+ADw-o:p+AD4APA-/o:p+AD4APA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p align+AD0-center style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:center'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-SECTION 3+ADw-br+AD4- +ADw-u+AD4-OPERATION OF NEWCO+ADw-/u+AD4APA-/span+AD4APA-/p+AD4- +ADw-p align+AD0-center style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:center'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-3.1+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Purpose, Company Name and Business Plan+ADw-/u+AD4-. The purpose of NewCo shall be to engage in the Business. The Shareholders shall cause the Board of Directors of NewCo to adopt as its five (5) year business plan the Initial Business Plan attached hereto as +ADw-u+AD4-Attachment 2+ADw-/u+AD4- (the +IBwAPA-b+AD4APA-u+AD4-Initial Business Plan+ADw-/u+AD4APA-/b+AD4gHQ-). The Shareholders intend the Initial Business Plan to be a planning document only and not to constitute a binding commitment of any of the parties hereto. The Shareholders shall cause the Board of Directors to formulate each year an Annual Business Plan in a manner that is consistent with the Initial Business Plan, with each such Annual Business Plan to be approved by the Board of Directors in accordance with the By-laws and Sections 2.3(f) and (h), and if an Annual Business Plan would result in NewCo taking any of the actions set forth in Section 2.2(d), the approval of the Shareholders shall (if given) be in accordance with Sections 2.2(b), (c) and (d). The officers of NewCo shall through their performance of their respective duties conduct and implement any such Annual Business Plan so approved. The Shareholders shall procure that the Annual Business Plan for the first fiscal year of NewCo attached hereto as +ADw-u+AD4-Schedule 3.1+ADw-/u+AD4-, is approved and adopted by the Board of Directors within two (2) months from the Effective Date.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4-+ADw-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-3.2+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Fiscal Year+ADw-/u+AD4-. The fiscal year of NewCo shall commence on April 1st and end on March 31st of each calendar year.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-3.3+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Financial Statements+ADw-/u+AD4-. NewCo shall, at its cost and expense, prepare consolidated balance sheets, profit and loss statements and statements of cash flow on a quarterly and annual basis in accordance with US GAAP consistently applied (and, to the extent practicable, consistent with the accounting principles and method of presentation used in Cytori+IBk-s financial statements) and provide copies of the same to each Shareholder within thirty (30) and forty-five (45) days after the end of each quarterly and annual period, respectively, as applicable. If requested by Olympus, NewCo shall, at its cost and expense, prepare consolidated balance sheets, profit and loss statements and statements of cash flow on a quarterly and annual basis in accordance with Japan+IBk-s accounting principals consistently applied (and, to the extent practicable, consistent with the accounting principles and method of presentation used in Olympus+IBk- financial statements) and provide copies of the same to each Shareholder within thirty (30) and forty-five (45) days after the end of each quarterly and annual period, respectively, as applicable.Annual consolidated financial statements shall, at NewCo+IBk-s cost and expense, be audited by an accounting firm of international standing and repute in accordance with the generally accepted auditing principles applicable in the+ADw-/span+AD4APA-/p+AD4- +ADw-p align+AD0-center style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:center'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-div+AD4- +ADw-div class+AD0-MsoNormal+AD4- +ADw-hr size+AD0-2 width+AD0AIg-100+ACUAIg- noshade color+AD0-gray align+AD0-left+AD4- +ADw-/div+AD4- +ADw-/div+AD4- +ADw-span style+AD0-'font-size:12.0pt+ADs-font-family:+ACI-Times New Roman+ACIAOw-mso-fareast-font-family: +ACI-Times New Roman+ACIAOw-mso-ansi-language:EN-US+ADs-mso-fareast-language:EN-US+ADs- mso-bidi-language:AR-SA'+AD4APA-br clear+AD0-all style+AD0-'page-break-before:always'+AD4- +ADw-/span+AD4- +ADw-p align+AD0-center style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:center'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-United States, and the audit report shall be provided to each Shareholder within sixty (60) days after the end of the relevant fiscal year.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-3.4+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Reporting+ADw-/u+AD4-. In addition to Section 3.3 and all other information to which a Shareholder may have the right to receive under the laws of the State of Delaware, within fifteen (15) days after the end of each month, NewCo shall, at its cost and expense, provide each Shareholder with the following monthly unaudited financial statements: (a) balance sheet, (b) profit +ACY-amp+ADs- loss and (c) cash flow. Upon the reasonable request of a Shareholder, NewCo shall, at the cost and expense of such requesting Shareholder, promptly provide such Shareholder any additional statements and information requested by such Shareholder (including, without limitation, such additional statements and information as may be reasonably necessary in order for a Shareholder to comply with its obligations under applicable Laws, including, without limitation, securities Laws and the rules and regulations of relevant stock exchanges).+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-3.5+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Rights of Inspection+ADw-/u+AD4-. The Shareholders (subject to the Three-Way NDA) shall have the right to inspect NewCo+IBk-s books and records+ADs- provided that (i)+ACY-nbsp+ADs-the fees of such inspection and all other costs associated with such inspection shall be borne by the Shareholder conducting the inspection, and (ii)+ACY-nbsp+ADs-such examination shall take place during normal business hours and in a manner that is not disruptive to the business of NewCo.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-3.6+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Books and Records+ADw-/u+AD4-. NewCo shall at all times maintain complete, accurate and up to date books of account and records of all its operations and accounts, in full compliance with US GAAP. Such books of account and records shall be retained by NewCo for at least seven (7) years after the fiscal year to which they pertain.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-3.7+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-International Accounting Firm+ADw-/u+AD4-. The independent auditor of NewCo shall be an accounting firm of international standing and repute, and shall be subject to the prior written approval of both Shareholders as provided under Section 2.2(d)(vii).+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p align+AD0-center style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:center'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-SECTION 4+ADw-br+AD4- SHARES, RESTRICTIONS ON TRANSFERS, ADDITIONAL CAPITAL +ADw-u+AD4-CONTRIBUTIONS AND RELATED MATTERS+ADw-/u+AD4APA-/span+AD4APA-/p+AD4- +ADw-p align+AD0-center style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:center'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-4.1+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Shares+ADw-/u+AD4-. NewCo shall ensure that all Shares shall be represented by stock certificates that shall contain the following legend:+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin-top:0in+ADs-margin-right:0in+ADs-margin-bottom:0in+ADs-margin-left:.5in+ADs- margin-bottom:.0001pt'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4gHA-The sale or transfer of the shares represented by this certificate is restricted by the terms of a Shareholders+IBk- Agreement among Olympus-Cytori, Inc. and its Shareholders, a copy of which may be inspected at the principal office of the Company. THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.+IB0APA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin-top:0in+ADs-margin-right:0in+ADs-margin-bottom:0in+ADs-margin-left:.5in+ADs- margin-bottom:.0001pt'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-and any additional legends that may be required by applicable Laws.+ADw-/span+AD4APA-/p+AD4- +ADw-p align+AD0-center style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:center'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-div+AD4- +ADw-div class+AD0-MsoNormal+AD4- +ADw-hr size+AD0-2 width+AD0AIg-100+ACUAIg- noshade color+AD0-gray align+AD0-left+AD4- +ADw-/div+AD4- +ADw-/div+AD4- +ADw-span style+AD0-'font-size:12.0pt+ADs-font-family:+ACI-Times New Roman+ACIAOw-mso-fareast-font-family: +ACI-Times New Roman+ACIAOw-mso-ansi-language:EN-US+ADs-mso-fareast-language:EN-US+ADs- mso-bidi-language:AR-SA'+AD4APA-br clear+AD0-all style+AD0-'page-break-before:always'+AD4- +ADw-/span+AD4- +ADw-p align+AD0-center style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:center'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-4.2+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- +ADw-u+AD4-Restrictions on Share Transfers+ADw-/u+AD4-.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(a)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- Neither Shareholder shall sell, assign, or otherwise transfer all or any portion of its Shares to any third party on or before+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAKgAqACoAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs-. Any and all sales, assignments and transfers of a Shareholder+IBk-s Shares after+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAKgAqACoAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs-to any third party shall be subject to this Section 4.2.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(s)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- After+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAKgAqACoAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs-, a Shareholder may, upon prior written consent of the other Shareholder, sell, assign or otherwise transfer its Shares to its Affiliates that agree in writing to assume all of the obligations of such transferring Shareholder under this Agreement arising from and after the effective date of any such transfer (+IBwAPA-b+AD4APA-u+AD4-Permitted Transfers+ADw-/u+AD4APA-/b+AD4gHQ-), provided that such consent shall not be unreasonably withheld. In the case of any Permitted Transfer of some or all of a Shareholder+IBk-s Shares, for all purposes of this Agreement, all of the Shares shall be treated as if they were still owned only by the Shareholder. The Shareholder shall procure that any of its Affiliates which own Shares (each a +IBwAPA-b+AD4APA-u+AD4-Permitted Transferee+ADw-/u+AD4APA-/b+AD4gHQ-) shall sign written consent actions and vote consistently with the Shareholder, in order to ensure formal compliance with corporate governance Laws.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(t)+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs- Except for Permitted Transfers, any and all sale, assignment or transfer of any Shares after+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAKgAqACoAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs-shall be subject to the following:+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:1.0in+ADs-text-autospace: none'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-If any Shareholder (or such Shareholder+IBk-s Permitted Transferree) proposes to sell, assign or otherwise transfer any or all of its Shares to any Person that is not an Affiliate of such Shareholder (or if any Person that is not an Affiliate of such Shareholder proposes to buy the Shares held by a Shareholder), such transferring Shareholder (the +IBwAPA-b+AD4APA-u+AD4-Transferor+ADw-/u+AD4APA-/b+AD4gHQ-) shall first offer the Shares that the Transferor desires to sell (the +IBwAPA-b+AD4APA-u+AD4-Offered Shares+ADw-/u+AD4APA-/b+AD4gHQ-) to the other Shareholder (the +IBwAPA-b+AD4APA-u+AD4-Offeree Shareholder+ADw-/u+AD4APA-/b+AD4gHQ-). Such offer shall be made by delivery of a written offer (the +IBwAPA-b+AD4APA-u+AD4-Offer+ADw-/u+AD4APA-/b+AD4gHQ-), within thirty (30) days of the original offer to or by the Transferor for the proposed transfer setting forth: (i) a description of the proposed transfer+ADs- (ii) the name and address of each bona fide prospective purchaser (the +IBwAPA-b+AD4APA-u+AD4-Transferee+ADw-/u+AD4APA-/b+AD4gHQ-) (including in the case of any Transferee who is not an individual, the names and addresses of the Person(s) directly or indirectly controlling such Transferee+ADs- and (iii) any and all other material terms (the +IBwAPA-b+AD4APA-u+AD4-Terms+ADw-/u+AD4APA-/b+AD4gHQ-) of the proposed transfer, including without limitation, the purchase price for the Offered Shares offered by each Transferee (+IBwAPA-b+AD4APA-u+AD4-Transfer Price+ADw-/u+AD4APA-/b+AD4gHQ-), the manner in which the Transfer Price shall be paid, and the date on which such proposed transfer will be completed or consummated. The Offeree Shareholder may elect to purchase such Offered Shares by giving written notice to the Transferor within forty (40) days of the date the Offeree Shareholder received the Offer. Such written notice from the Offeree Shareholder must indicate that the Offeree Shareholder is willing to purchase up to one hundred percent (100+ACU-) of the Offered Shares at the Transfer Price and on the Terms (as near as may be), or the Offeree Shareholder shall not have the right to purchase any of the Offered Shares. If the Offeree Shareholder provides such notice, the Offeree Shareholder shall purchase and the Transferor shall sell the Offered Shares in accordance with the Terms. If the Offeree Shareholder does not provide such notice within such forty (40) day period, the Transferor may sell the Offered Shares but only in accordance with the Terms. If the Transferor fails or is otherwise unable to consummate the transfer to the Offered Shares in accordance with the Terms within ninety (90) days thereafter, any subsequent proposed transfer shall be subject to this Section 4.2. In the event of any transfers of all or substantially all (i.e., over 85+ACU-) of the Shareholder+IBk-s Shares to a non-Affiliate pursuant to this Section 4.2(c), Transferor shall, prior to any such transfer of Shares, deliver to the Offeree Shareholder a written document, effective as of the date of completion of such transfer, duly and validly executed by the proposed Transferee and Transferor, which provides that, to the extent consistent with the number of Shares transferred:+ADw-o:p+AD4APA-/o:p+AD4APA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(A) Transferor assigns and delegates to Transferee all rights and obligations arising under this Shareholders Agreement after the transfer of Shares pursuant to Section 4.2(c) (it being understood that assignor also remains responsible for its obligations hereunder)+ADs- and+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt'+AD4-+ADw-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-div+AD4- +ADw-div class+AD0-MsoNormal+AD4- +ADw-hr size+AD0-1 width+AD0AIg-25+ACUAIg- noshade color+AD0-black align+AD0-left+AD4- +ADw-/div+AD4- +ADw-/div+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AKgAqACo- Material has been omitted pursuant to a request for confidential treatment filed separately with the Securities and Exchange Commission.+ADw-/span+AD4APA-/p+AD4- +ADw-p align+AD0-center style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:center'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-div+AD4- +ADw-div class+AD0-MsoNormal+AD4- +ADw-hr size+AD0-2 width+AD0AIg-100+ACUAIg- noshade color+AD0-gray align+AD0-left+AD4- +ADw-/div+AD4- +ADw-/div+AD4- +ADw-span style+AD0-'font-size:12.0pt+ADs-font-family:+ACI-Times New Roman+ACIAOw-mso-fareast-font-family: +ACI-Times New Roman+ACIAOw-mso-ansi-language:EN-US+ADs-mso-fareast-language:EN-US+ADs- mso-bidi-language:AR-SA'+AD4APA-br clear+AD0-all style+AD0-'page-break-before:always'+AD4- +ADw-/span+AD4- +ADw-p align+AD0-center style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-align:center'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(B) Transferee accepts such assignment and delegation from the Transferor and agrees to become a party to the Shareholders Agreement, entitled to any and all benefits and advantages imposed in connection therewith, and agrees to observe, duly perform and be liable under and bound by each and every covenant, agreement and condition to be observed or performed under this Shareholders Agreement, as if the Transferee was an original signatory hereto (it being understood that assignor also remains responsible for its obligations hereunder).+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-(C) The Transferor and Transferee agree to be jointly and severally liable for any and all liabilities arising from or in connection with (i) Shareholders Agreement or the Ancillary Agreement, regardless as of whether such liability arise from any circumstance, occurrence or event that occur on, before or after the transfer of Share pursuant to this Section 4.2 (c) and (ii) Transferror+IBk-s status as a shareholder of NewCo prior to such transfer.+ADw-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4AJg-nbsp+ADsAPA-/span+AD4APA-/p+AD4- +ADw-p style+AD0-'margin:0in+ADs-margin-bottom:.0001pt+ADs-text-indent:.5in'+AD4APA-span style+AD0-'font-size:10.0pt'+AD4-4.3+ACY-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADsAJg-nbsp+ADs
 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more